A prospective, international, multi-center, non-randomized, open label study (HERO) of health outcomes and the rates of explants and reoperations after 5 years of treatment with laparoscopic adjustable gastric banding

In the15 years that laparoscopic adjustable gastric banding (LAGB) has been approved in the U.S. there have been advances in the technology, surgical technique, and aftercare that have led to clear improvements in health outcomes and reductions in explants and reoperations.